In a new study the administration of the marijuana compound cannabidiol (CBD) “decreased daytime drowsiness and was associated with a lower prevalence of low testosterone levels in older men as compared to age-adjusted population norms.”
“Previous research indicated that cannabidiol (CBD) may result in low levels of male total testosterone (TT), elevations in liver tests (LTs), and daytime drowsiness (DD)”, states the study’s abstract. “We investigated the prevalences of TT and LT in a large adult sample self-administering CBD and determined the effect self-dosing of CBD has on the severity of DD.”
Published in the peer-reviewed journal Medical Cannabis and Cannabinoids and epublished by the U.S. National Library of Medicine, the study was conducted by researchers at Tarleton State University (Texas), the University of Chicago (Illinois), Syzygy Research Solutions (Florida) and the Midwest Allergy Sinus Asthma PC (Illinois).
Continue reading